Acorah Software Products - Accounts Production 15.0.600 false true false true No description of principal activity 17 April 2023 30 April 2024 30 April 2024 14807521 Olga Lund Vera Lund iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14807521 2023-04-16 14807521 2024-04-30 14807521 2023-04-17 2024-04-30 14807521 frs-core:CurrentFinancialInstruments 2024-04-30 14807521 frs-bus:PrivateLimitedCompanyLtd 2023-04-17 2024-04-30 14807521 frs-bus:FilletedAccounts 2023-04-17 2024-04-30 14807521 frs-bus:Micro-entities 2023-04-17 2024-04-30 14807521 frs-bus:AuditExempt-NoAccountantsReport 2023-04-17 2024-04-30 14807521 frs-bus:Director1 2023-04-17 2024-04-30 14807521 frs-bus:Director2 2023-04-17 2024-04-30
Registered number: 14807521
Lund's Pharma Ltd
Unaudited Financial Statements
For the Period 17 April 2023 to 30 April 2024
Accounting On You
Balance Sheet
Registered number: 14807521
30 April 2024
£
Fixed assets 4,800
Current assets 6,942
Creditors: Amounts Falling Due Within One Year (4,272 )
NET CURRENT ASSETS 2,670
TOTAL ASSETS LESS CURRENT LIABILITIES 7,470
NET ASSETS 7,470
CAPITAL AND RESERVES 7,470

Notes

1. General Information
Lund's Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14807521 . The registered office is 85 Westfield Lane, St. Leonards-On-Sea, TN37 7NF.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
3. Directors Advances, Credits and Guarantees
Dividends paid to directors
30 April 2024
£
Olga Lund 6,500
Page 0
Page 1
For the period ending 30 April 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Olga Lund
Director
30/08/2024